635 related articles for article (PubMed ID: 24345423)
1. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
[TBL] [Abstract][Full Text] [Related]
3. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
Hildebrandt GC; Granell M; Urbano-Ispizua A; Wolff D; Hertenstein B; Greinix HT; Brenmoehl J; Schulz C; Dickinson AM; Hahn J; Rogler G; Andreesen R; Holler E
Biol Blood Marrow Transplant; 2008 Jan; 14(1):67-74. PubMed ID: 18158963
[TBL] [Abstract][Full Text] [Related]
4. NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
van der Straaten HM; Paquay MM; Tilanus MG; van Geloven N; Verdonck LF; Huisman C
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1231-6. PubMed ID: 21215810
[TBL] [Abstract][Full Text] [Related]
5. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
[TBL] [Abstract][Full Text] [Related]
6. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.
Nguyen Y; Al-Lehibi A; Gorbe E; Li E; Haagenson M; Wang T; Spellman S; Lee SJ; Davidson NO
Blood; 2010 Apr; 115(17):3625-31. PubMed ID: 20177049
[TBL] [Abstract][Full Text] [Related]
7. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
van der Velden WJ; Blijlevens NM; Maas FM; Schaap NP; Jansen JH; van der Reijden BA; Feuth T; Dolstra H; Donnelly JP
Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
[TBL] [Abstract][Full Text] [Related]
9. Donor Nucleotide-Binding Oligomerization-Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation.
Grube M; Brenmoehl J; Rogler G; Hahn J; Herr W; Holler E
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1399-404. PubMed ID: 25988661
[TBL] [Abstract][Full Text] [Related]
10. ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.
Kuba A; Raida L; Mrazek F; Schneiderova P; Kriegova E; Furst T; Furstova J; Faber E; Ambruzova Z; Papajik T
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1136-40. PubMed ID: 25759145
[TBL] [Abstract][Full Text] [Related]
11. Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis.
Zhao H; Jia M; Wang Z; Cheng Y; Luo Z; Chen Y; Xu X; Yang S; Tang Y
Hematology; 2015 Jun; 20(5):254-62. PubMed ID: 25248089
[TBL] [Abstract][Full Text] [Related]
12. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G;
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Devillier R; Fürst S; El-Cheikh J; Castagna L; Harbi S; Granata A; Crocchiolo R; Oudin C; Mohty B; Bouabdallah R; Chabannon C; Stoppa AM; Charbonnier A; Broussais-Guillaumot F; Calmels B; Lemarie C; Rey J; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Mar; 20(3):370-4. PubMed ID: 24315846
[TBL] [Abstract][Full Text] [Related]
17. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
Granell M; Urbano-Ispizua A; Aróstegui JI; Fernández-Avilés F; Martínez C; Rovira M; Rius J; Plaza S; Gaya A; Navarro A; Talarn C; Carreras E; Monzó M; Montserrat E; Yagüe J
Haematologica; 2006 Oct; 91(10):1372-6. PubMed ID: 17018387
[TBL] [Abstract][Full Text] [Related]
18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
19. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
[TBL] [Abstract][Full Text] [Related]
20. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]